Relationships among microbiota, gastric cancer, and immunotherapy

Currently, conventional neoadjuvant therapy or postoperative adjuvant therapy, such as chemotherapy and radiation therapy, can only bring limited survival benefits to gastric cancer (GC). Median survival after palliative chemotherapy is also low, at about 8–10 months. Immunotargeting is a new option...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuzhen, Huang, Xiaona, Tong, Desheng, Jiang, Chenyu, Zhu, Xiaodan, Wei, Zhipeng, Gong, Tingjie, Jin, Chunhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511979/
https://www.ncbi.nlm.nih.gov/pubmed/36171746
http://dx.doi.org/10.3389/fmicb.2022.987763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511979/
https://www.ncbi.nlm.nih.gov/pubmed/36171746
http://dx.doi.org/10.3389/fmicb.2022.987763

Ejemplares similares